Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

– 2023 marked byCeapro’sachievement of key milestones and progress toward its next phase of growth

Related Keywords

Austria ,Montreal ,Quebec ,Canada ,Slovenia ,Canadian ,Austrian ,Beta Glucan ,Gillesr Gagnon ,Gilles Gagnon ,Prozesstechnologie Gmb ,Corealis Inc ,Montreal Heart Institute ,Manufacturing Services Corealis ,Ceapro Inc ,Avenanthramides Malted Technology ,Mcmaster University ,Aeterna Zentaris ,Altasciences Inc ,University Of Alberta ,Meeting Of The Wound Healing Society ,Health Canada ,Data Safety Monitoring Board ,Wound Healing Society ,Malting Technology ,Main Facility ,Food Engineering ,Oat Beta Glucan ,Novel Nutraceutical Product ,Michel Regnier ,Senior Vice President ,Operations Executive ,Professional Engineer ,Fourth Quarter ,Full Year ,Ended December ,Region ,